This text is a result of machine translation.
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Exclusive Interview with Song Xiangqian, Founding Partner and Chairman of Harvest Capital
Harvest Capital invests in key fast-growing sectors dominated by large-sized players. Its portfolio includes snack giants Qiaqia Food (002557) (Chinese: 洽洽食品) and LYFEN (Chinese: 来伊份), energy drink startup Eastroc Beverage (605499) (Chinese: 东鹏饮料), Chinese fast-food chain Home Original Chicken (Chinese: 老乡鸡), top on-demand local delivery and retail platform Meituan Dianping (03690) (Chinese: 美团点评) and Chinese ride-sharing behemoth Didi (DIDI: NYSE) (Chinese: 滴滴出行).
Updated 2 hours ago
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
Ophthalmological Medtech Startup Raises Tens of Mns of CNY in Series C Funding
Founded in 2011, Suzhou Microclear Medical is engaged in the ophthalmology and optometry imaging field. Microclear integrates self-developed components with artificial intelligence technology to provide high-quality devices and services for hospitals and basic medical institutes across the world.
Updated 14 mins ago
China Launch Startup Orienspace Raises Nearly USD 60 Mn in Series A Round
Facing the explosive demand of various satellite networks, Orienspace innovatively builds the “Gravity” series of medium-and-large-sized commercial launch vehicles, achieving the economies of scale
May 21, 2022 07:50 PM
Fengtai District of Beijing will lift the epidemic prevention zone of the whole region from now on.
Smart Mining Truck Maker Easymove Raises Tens of Mns of CNY in Angel Round
With the development of new energy industry, huge opportunities existed in vehicle electrification under different mobile scenarios, and construction machinery is one of the largest potential markets
May 21, 2022 02:29 PM
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
“We thought this battle would be over in one or two years, but it has been dragging on for three years, so this could conversely be an opportunity for us to focus on; in other words, amid the unexpected international and domestic situation, new opportunities will be seen.”
May 21, 2022 12:51 PM
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
Pharmaceutical and biological stocks continued to strengthen in the afternoon
The net purchase of 7 shares was more than 100 million yuan, and Ningde times was the most
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
May 21, 2022 12:51 PM